News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rainbow BioSciences, LLC Continues Negotiations With Amarantus MA



8/29/2012 10:03:15 AM

NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow BioSciences, the biotechnology subsidiary of Rainbow Coral Corp. (OTCBB: RBCC), continues its negotiations toward a definitive agreement with emerging biotech innovator Amarantus BioSciences (OTCBB: AMBS). RBCC is in talks to provide funding and expertise toward the development and marketing of one or more of Amarantus’ exciting medical breakthroughs. The company is developing thrilling new ways to effectively diagnose and treat devastating neurological disorders including Parkinson’s disease and Traumatic Brain Injury (TBI).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES